Skip to main content
40% Launch offerEnds 31 Dec 2026See plans
Umoja Biopharma logo

Umoja Biopharma

Biotech & Pharmaceuticals
WebsiteLinkedIn

We are working to improve the treatment experience for patients by developing in vivo CAR T cell therapies designed to be more accessible. Our flagship VivoVec platform generates CAR T cells directly in a patient’s body.

Open roles
2
Company size
51 - 200 employees
Headquarters
701 Dexter Ave N Suite 300, Seattle, WA 98109

Follow Umoja Biopharma

Create an exact-company alert for on-site matches and optional daily email.

Open roles